Activity (binding)
|
= 92.4 %
|
Inhibition of Arabidopsis thaliana P5C reductase catalytic activity assessed as residual concentration of enzyme at 535 nm OD at 0.5 mM by P5C utilization assay
|
ChEMBL.
|
17474756
|
Activity (binding)
|
= 101.4 %
|
Inhibition of Arabidopsis thaliana P5C reductase catalytic activity assessed as inhibition of NADPH oxidation at 340 nm OD at 0.2 mM by NADPH oxidation assay
|
ChEMBL.
|
17474756
|
IC50 (binding)
|
= -6.62
|
Inhibitory activity against farnesyl Pyrophosphate Synthase expressed as #NAME? (M)
|
ChEMBL.
|
14613320
|
IC50 (functional)
|
= -4.27
|
Predicted pIC50 against Tryomastigotes Brucei rhodesiense.
|
ChEMBL.
|
12086478
|
IC50 (functional)
|
= 5
|
Growth inhibition of Plasmodium falciparum
|
ChEMBL.
|
19053772
|
IC50 (binding)
|
= 0.069 mM
|
Inhibition of Oryza sativa cv. Gigante vercellese (rice) glutamine synthetase assessed as inhibition of glutamine synthesis from glutamic acid after 15 min by biosynthetic assay
|
ChEMBL.
|
15161194
|
IC50 (binding)
|
= 0.096 mM
|
Inhibition of Oryza sativa cv. Gigante vercellese (rice) glutamine synthetase after 30 min by hemibiosynthetic assay
|
ChEMBL.
|
15161194
|
IC50 (binding)
|
= 1.04 mM
|
Inhibition of Oryza sativa cv. Gigante vercellese (rice) glutamine synthetase by transferase assay
|
ChEMBL.
|
15161194
|
IC50 (binding)
|
= 0.24 uM
|
Inhibitory activity against Leishmania major Farnesyl-diphosphatesynthase (FPP synthase)
|
ChEMBL.
|
14695831
|
IC50 (binding)
|
= 0.24 uM
|
Inhibitory activity against farnesyl Pyrophosphate Synthase was determined
|
ChEMBL.
|
14613320
|
IC50 (binding)
|
= 0.24 uM
|
Inhibitory activity against Leishmania major Farnesyl-diphosphatesynthase (FPP synthase)
|
ChEMBL.
|
14695831
|
IC50 (binding)
|
= 0.24 uM
|
Inhibitory activity against farnesyl Pyrophosphate Synthase was determined
|
ChEMBL.
|
14613320
|
IC50 (binding)
|
= 7 uM
|
Inhibition of Escherichia coli DXR
|
ChEMBL.
|
21379374
|
IC50 (functional)
|
= 10.6 uM
|
In vitro growth inhibition against Plasmodium falciparum
|
ChEMBL.
|
14695831
|
IC50 (functional)
|
= 10.6 uM
|
In vitro growth inhibition against Plasmodium falciparum
|
ChEMBL.
|
14695831
|
IC50 (functional)
|
= 11 uM
|
Growth inhibition of Plasmodium falciparum
|
ChEMBL.
|
19053772
|
IC50 (functional)
|
= 11 uM
|
Antimicrobial activity against Plasmodium falciparum
|
ChEMBL.
|
20185316
|
IC50 (functional)
|
= 53.3 uM
|
In vitro growth inhibition of blood-stream-form Trypanosoma brucei rhodesiense Trypomastigotes
|
ChEMBL.
|
12086478
|
IC50 (functional)
|
= 53.3 uM
|
In vitro growth inhibition of blood-stream-form Trypanosoma brucei rhodesiense Trypomastigotes
|
ChEMBL.
|
12086478
|
IC50 (functional)
|
= 87 uM
|
In vitro growth inhibition against Entamoeba histolytica
|
ChEMBL.
|
14695831
|
IC50 (functional)
|
= 87 uM
|
In vitro growth inhibition against Entamoeba histolytica
|
ChEMBL.
|
14695831
|
IC50 (functional)
|
= 87 uM
|
Antimicrobial activity against Entamoeba histolytica
|
ChEMBL.
|
20185316
|
Inhibition (binding)
|
|
Inhibition of Mycobacterium tuberculosis recombinant DXR expressed in Escherichia coli BL21 (DE3) using DXP as substrate and MgCl2 as cofactor at 100 uM preincubated for 10 mins
|
ChEMBL.
|
21561155
|
Inhibition (binding)
|
= 13.9 %
|
Inhibition of Oryza sativa cv. Gigante vercellese (rice) glutamine synthetase assessed as inhibition of glutamine synthesis from glutamic acid at 1 mM after 15 min by biosynthetic assay
|
ChEMBL.
|
15161194
|
Inhibition (binding)
|
= 17.5 %
|
Inhibition of Oryza sativa cv. Gigante vercellese (rice) glutamine synthetase at 1 mM after 30 min by hemibiosynthetic assay
|
ChEMBL.
|
15161194
|
Inhibition (binding)
|
= 52.8 %
|
Inhibition of Oryza sativa cv. Gigante vercellese (rice) glutamine synthetase at 1 mM by transferase assay
|
ChEMBL.
|
15161194
|
IZ (functional)
|
= 9 mm
|
Antibacterial activity against Escherichia coli pTMV19
|
ChEMBL.
|
17149863
|
IZ (functional)
|
= 9 mm
|
Antibacterial activity against Escherichia coli pTMV19
|
ChEMBL.
|
17149863
|
IZ (functional)
|
= 12 mm
|
Antibacterial activity against Escherichia coli pTMV19 in presence of mevalonate
|
ChEMBL.
|
17149863
|
IZ (functional)
|
= 12 mm
|
Antibacterial activity against Escherichia coli pTMV19 in presence of mevalonate
|
ChEMBL.
|
17149863
|
IZ (functional)
|
= 13 mm
|
Antibacterial activity against Escherichia coli W3110
|
ChEMBL.
|
17149863
|
IZ (functional)
|
= 13 mm
|
Antibacterial activity against Escherichia coli W3110
|
ChEMBL.
|
17149863
|
Ki (binding)
|
= 0.023 uM
|
Binding affinity towards farnesyl Pyrophosphate Synthase using [14C]- isopentenyl pyrophosphate as radioligand
|
ChEMBL.
|
14613320
|
Ki (binding)
|
= 0.023 uM
|
Binding affinity towards farnesyl Pyrophosphate Synthase using [14C]- isopentenyl pyrophosphate as radioligand
|
ChEMBL.
|
14613320
|
LD50 (ADMET)
|
> 991 uM
|
Toxicity evaluated against human nasopharyngeal carcinoma KB cell line
|
ChEMBL.
|
14695831
|
LD50 (ADMET)
|
> 991 uM
|
Toxicity evaluated against human nasopharyngeal carcinoma KB cell line
|
ChEMBL.
|
14695831
|
LD50 (ADMET)
|
> 992 uM
|
50% lethal dose for inhibition of KB cells growth
|
ChEMBL.
|
12086478
|
LD50 (ADMET)
|
> 992 uM
|
50% lethal dose for inhibition of KB cells growth
|
ChEMBL.
|
12086478
|
LED (functional)
|
= 0.01 mgP kg-1
|
Bone resorption activity in rats.
|
ChEMBL.
|
12086477
|
Log IC50 (functional)
|
= 4.27
|
Predicted pIC50 against Tryomastigotes Brucei rhodesiense.
|
ChEMBL.
|
12086478
|
Log IC50 (binding)
|
= 6.62
|
Inhibitory activity against farnesyl Pyrophosphate Synthase expressed as #NAME? (M)
|
ChEMBL.
|
14613320
|
TI (ADMET)
|
> 11.4
|
Therapeutic index was expressed as ratio of LD50 for KB cell line to IC50 against Entamoeba histolytica
|
ChEMBL.
|
14695831
|
TI (ADMET)
|
> 19
|
Therapeutic index measured as the ratio of LD50 (KB cells) to IC50 (T.b. rhodesiense)
|
ChEMBL.
|
12086478
|
TI (ADMET)
|
> 93.5000000000001
|
Therapeutic index was expressed as ratio of LD50 for KB cell line to IC50 against Plasmodium falciparum
|
ChEMBL.
|
14695831
|